Oberweis Asset Management’s Protalix BioTherapeutics PLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-5,420	Closed	-$246K	–	151
2013 Q3	$246K	Sell	5,420 -5,580	-51%	-$253K	0.07%	121
2013 Q2	$540K	Buy	+11,000	New	+$540K	0.15%	96